Lu stuart (45 risultati)

paperback. Condizione: Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority.

paperback. Condizione: New.

Condizione: New. Wildgoose, Chris (illustratore).

Condizione: As New. Unread book in perfect condition. Wildgoose, Chris (illustratore).

Paperback. Condizione: New. Wildgoose, Chris (illustratore).

Soft cover. Condizione: Very Good. Has some light general reading/shelfwear - otherwise, this is a clean, tight copy. Dispatch within 24hrs from the UK. Book.

Paperback. Condizione: Used; Good. ***Simply Brit*** Welcome to our online used book store, where affordability meets great quality. Dive into a world of captivating reads without breaking the bank. We take pride in offering a wide selection of used books, from classics to hidden gems, ensuring there is something for every literary palate. All orders are shipped within 24 hours and our lightning fast-delivery within 48 hours coupled with our prompt customer service ensures a smooth journey from ordering to delivery. Discover the joy of reading with us, your trusted source for affordable books that do not compromise on quality. Wildgoose, Chris (illustratore).…

Condizione: New. In.

Paperback. Condizione: Brand New. 100 pages. 9.00x6.00x0.25 inches. In Stock.

Condizione: New. Wildgoose, Chris (illustratore).

Condizione: As New. Unread book in perfect condition. Wildgoose, Chris (illustratore).

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: New. Print on Demand.

Condizione: good. Supports Goodwill of Silicon Valley job training programs. The cover and pages are in Good condition! Any other included accessories are also in Good condition showing use. Use can include some highlighting and writing, page and cover creases as well as other types visible wear.

Condizione: new. Condizione sovraccoperta: new. We ship worldwide. 100% guarentee.NEW.

Condizione: New.

paperback. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority.

Condizione: good. This book is in good condition. The cover has minor creases or bends. The binding is tight and pages are intact. Some pages may have writing or highlighting.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: As New. Unread book in perfect condition.

paperback. Condizione: New. Paperback Pages Number: 830 Language: Chinese. Macroeconomics and microeconomics of the book is set as a whole. done a detailed description of the enterprise economy and business management. financial and monetary. environmental economics. international economics. the content novel. wide coverage. The book discusses 30 aspects more specific. the real problem. which discussed. such as environmental economics. transportation. regional and urban policy and social policy issues for China's econom.…

Condizione: New.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Hardback. Condizione: New. Pharmaceuticals constitute a relatively small share of the total healthcare expenditure in most developed economies, and yet they play a critical role in the ongoing debate over how best to advance, improve, and afford healthcare. Despite this, and perhaps because of this, the industry has had, for many years, an outsized claim to fame and controversy, praise and criticisms, support and condemnation. Unfortunately, many participants in the debate do not fully understand the complexities of the industry and its role in the overall healthcare system. The analytical tools of economics provide a strong foundation for a better understanding of the dynamics of the pharmaceutical industry, its contribution to health and healthcare, its dual and often conflicting priorities of affordability and innovation, as well as the various private and public policy initiatives directed at the sector. This third edition of a uniquely comprehensive and balanced examination of the industry includes several new chapters on important topics such as the full-fledged generics sector, the arrival of biosimilars or generic biological drugs, the global consolidation of manufacturers, the evolving reimbursement landscape, and the emergence of the world's most populous nations, such as China, India, and Brazil, as both suppliers and consumers of pharmaceutical products. Other chapters have been fully rewritten or extensively updated, covering such important topics as the cost efficiency of research and development, pace of new innovations, economic evaluation and value-based pricing of drugs, and public and private interventions in the industry. …

paperback. Condizione: New. Paperback. Pub Date: June 2010 Pages: 235 Language: Chinese in Publisher: Henan University Press cultural identity Introduction agreed to explore the topic in the next articles. and provide their own interpretation to solve Why identity problem has become so compelling. and so deconstruction and the free form of a center. However. this Introduction and cultural identity as a whole are not themselves provide a complete explanation. or even the outline of the framework. Readers should not expec. …

Hardback. Condizione: New. Pharmaceuticals constitute a relatively small share of the total healthcare expenditure in most developed economies, and yet they play a critical role in the ongoing debate over how best to advance, improve, and afford healthcare. Despite this, and perhaps because of this, the industry has had, for many years, an outsized claim to fame and controversy, praise and criticisms, support and condemnation. Unfortunately, many participants in the debate do not fully understand the complexities of the industry and its role in the overall healthcare system. The analytical tools of economics provide a strong foundation for a better understanding of the dynamics of the pharmaceutical industry, its contribution to health and healthcare, its dual and often conflicting priorities of affordability and innovation, as well as the various private and public policy initiatives directed at the sector. This third edition of a uniquely comprehensive and balanced examination of the industry includes several new chapters on important topics such as the full-fledged generics sector, the arrival of biosimilars or generic biological drugs, the global consolidation of manufacturers, the evolving reimbursement landscape, and the emergence of the world's most populous nations, such as China, India, and Brazil, as both suppliers and consumers of pharmaceutical products. Other chapters have been fully rewritten or extensively updated, covering such important topics as the cost efficiency of research and development, pace of new innovations, economic evaluation and value-based pricing of drugs, and public and private interventions in the industry. …